These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27154527)

  • 1. Severe Torsades de Pointes with acquired QT prolongation.
    Narang A; Ozcan C
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):775-776. PubMed ID: 27154527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug induced QT prolongation].
    Altmann D; Eggmann U; Ammann P
    Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of acquired QT prolongation and torsades de pointes.
    Thomas SH; Behr ER
    Br J Clin Pharmacol; 2016 Mar; 81(3):420-7. PubMed ID: 26183037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive Discordant T-Wave Alternans and Imminent Torsades de Pointes: The "Elephant in the Room".
    Ola O; Gharacholou SM; Del-Carpio Munoz F
    JAMA Intern Med; 2021 Oct; 181(10):1393-1395. PubMed ID: 34459879
    [No Abstract]   [Full Text] [Related]  

  • 5. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome.
    Hoshino K; Ogawa K; Hishitani T; Isobe T; Etoh Y
    Pediatr Int; 2006 Apr; 48(2):112-7. PubMed ID: 16635167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical approach to torsade de pointes.
    Roden DM
    Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes and long QT syndromes.
    Janeira LF
    Am Fam Physician; 1995 Oct; 52(5):1447-53. PubMed ID: 7572567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachycardia and prolonged QT interval presenting as seizure-like activity.
    Wentlandt M; Morris SC; Mitchell SH
    Am J Emerg Med; 2017 May; 35(5):804.e5-804.e6. PubMed ID: 27914889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature atrial contraction induces torsades de pointes in a patient of Takotsubo cardiomyopathy with QT prolongation.
    Kawano H; Matsumoto Y; Arakawa S; Satoh O; Hayano M
    Intern Med; 2010; 49(16):1767-73. PubMed ID: 20720356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine-induced torsades de pointes in idiopathic long Q-T syndrome.
    Singh N; Singh HK; Singh PP; Khan IA
    Am J Ther; 2001; 8(4):299-302. PubMed ID: 11441329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
    J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome.
    Hoshino K; Ogawa K; Hishitani T; Isobe T; Eto Y
    J Am Coll Nutr; 2004 Oct; 23(5):497S-500S. PubMed ID: 15466950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hands-on help Torsades de pointes.
    Dulak SB
    RN; 2004 Oct; 67(10):24ac1-4. PubMed ID: 15552376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsades de pointes: prevention and therapy.
    Keren A; Tzivoni D
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):509-13. PubMed ID: 1854660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D
    Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsades de pointes following cardioversion: case history and literature review.
    Spearritt D
    Aust Crit Care; 2003 Nov; 16(4):144-9. PubMed ID: 14692159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.